BOLERO-4: Phase 2 Trial of First-Line Everolimus (Eve) plus Letrozole (Let) in Estrogen Receptor-Positive (Er plus ), Human Epidermal Growth Factor Receptor 2-Negative (Her2-) Advanced Breast Cancer (Bc)

AuthID
 P-00M-GBS
14
Author(s)
Villanueva, C
·
Ozguroglu, M
·
Bachelot, T
·
Azevedo, S
·
Melo Cruz, FM
·
Hegg, R
·
Debled, M
·
Gradishar, WJ
·
Manlius, C
·
Ridolfi, A
·
Lin, J
·
Ringeisen, F
·
Cardoso, F
Document Type
Abstract
Year published
2016
Published
in ANNALS OF ONCOLOGY, ISSN: 0923-7534
Volume: 27
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:000393912500221
Source Identifiers
ISSN: 0923-7534
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service